Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)

K Yamakawa, R Yamamoto, T Terayama… - Acute medicine & …, 2021 - Wiley Online Library
Background The coronavirus disease 2019 (COVID‐19) has spread worldwide since early
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …

Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (September 2021)

K Yamakawa, R Yamamoto… - Acute medicine & …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID-19) has spread worldwide since early
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …

[HTML][HTML] Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)

K Yamakawa, R Yamamoto, T Terayama… - Acute Medicine & …, 2021 - ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID‐19) has spread worldwide since early
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)

K Yamakawa, R Yamamoto, T Terayama… - Acute Medicine & …, 2021 - search.proquest.com
Background The coronavirus disease 2019 (COVID‐19) has spread worldwide since early
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …

Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (September 2021).

K Yamakawa, R Yamamoto, T Terayama… - Acute Medicine & …, 2021 - europepmc.org
Background The coronavirus disease 2019 (COVID-19) has spread worldwide since early
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)

K Yamakawa, R Yamamoto, T Terayama… - Acute Medicine & …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> The coronavirus disease 2019
(COVID‐19) has spread worldwide since early 2020, and there are still no signs of …

Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (September 2021)

K Yamakawa, R Yamamoto… - Acute medicine & …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID-19) has spread worldwide since early
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …